Anti-GluN2C/NR2C Antibody (N422/18)

Our Anti-GluN2C/NR2C mouse monoclonal primary antibody from NeuroMab is produced in-house from hybridoma clone N422/18. It is KO validated, detects human, mouse, and rat GluN2C/NR2C, and is purified by Protein A chromatography. It is great for use in IHC, ICC, WB.

SKU: 75-411

Volume: 100 µL
1-2 business days
Sale price$319.00

Product Specific References for Applications and Species

Western Blot: Mouse
PMID Dilution Publication
358677971:500Shelkar, G.P., et al. 2022. Cocaine Preference and Neuroadaptations are Maintained by Astrocytic NMDA Receptors in the Nucleus Accumbens. Science Advances, eabo6574.
334215651:1000Liu, J., et al. 2021. Facilitation of GluN2C-containing NMDA receptors in the external globus pallidus increases firing of fast spiking neurons and improves motor function in a hemiparkinsonian mouse model. Neurobiology Disorders, 105254.
311101971:1000Shelkar, G.P., et al. 2019. Differential effect of NMDA receptor GluN2C and GluN2D subunit ablation on behavior and channel blocker-induced schizophrenia phenotypes. Scientific Reports, 7572.
Western Blot: Rat
PMID Dilution Publication
27845401not listedChung, C., et al. 2016. Neuroprotection Mediated through GluN2C-Containing N-methyl-D-aspartate (NMDA) Receptors Following Ischemia. Scientific Reports, 37033.

Related Products

Recently Viewed